Abbott's denosumab biosimilar is the first approved in Thailand, making advanced therapy for osteoporosis and cancer-related bone loss more affordable for millions of Thais ...

Griffith University begins a world-first clinical trial using nasal cells to repair spinal cord injuries, offering new hope for people living with paralysis.